Trump’s tariffs focusing on BRICS nations have escalated dramatically, and President Donald Trump introduced a blanket 10% tariff on BRICS bloc members alongside potential 200% levies on pharmaceutical imports. This aggressive stance threatens to set off an India US commerce conflict, significantly focusing on India’s pharmaceutical exports. The pharmaceutical tariffs might additionally disrupt provide chains whereas BRICS greenback commerce initiatives face mounting stress from US commerce protectionism measures.
Right here’s Why Trump Tariffs Threaten BRICS Bloc, India’s Exports, And Commerce
BRICS Beneath Financial Siege
Trump’s tariffs on BRICS just isn’t merely monetary politics actually, however a symbolic blow in opposition to a bunch that’s threatening the US dominance in varied very important sectors of the economic system. BRICS makes up greater than 32 % of world GDP and greater than 40 % of world inhabitants, and initiatives to commerce extra on native currencies and cease relying on greenback which has modified many main market dynamics.
In accordance with the Workplace of america Commerce Consultant (USTR), the mixture US imports of BRICS international locations had been within the determine of $886 billion within the 12 months 2024. The ten% tariff would impose greater than 88 billion additional duties, which might stall BRICS progress and greenback decoupling in several main buying and selling techniques. This India US commerce conflict positioning has pitted India on the bloc solidarity or bilateral dependency to varied key strategic selections.
India’s Pharmaceutical Sector Focused
Trump’s 200% tariff risk on prescribed drugs strikes at India’s export spine and has revolutionized sure crucial facets of commerce relations. India exported prescribed drugs value $9.8 billion to the US in 2024-25, a 21% improve accounting for over 30% of all Indian drug exports throughout a number of important market segments. These pharmaceutical tariffs would drastically elevate costs within the US market, disrupting provide chains and doubtlessly triggering home drug shortages that would affect quite a few vital healthcare sectors.
American shoppers, particularly Medicare and Medicaid beneficiaries, would bear the brunt of worth hikes throughout varied main healthcare techniques. In Texas, California, and Florida—main recipients of Indian pharma shipments—this might ripple via the political panorama as healthcare prices soar involving a number of key demographic teams.
Commerce Battle Implications
The escalation of Trump’s tariffs on BRICS marks a turning level in international commerce dynamics and has pioneered sure crucial modifications throughout a number of strategic areas. India’s $2 billion copper export sector faces a 50% tariff risk, with the US accounting for $360 million of exports involving varied main industrial functions. This US commerce protectionism strategy erodes competitiveness for Indian producers, significantly in Gujarat and Tamil Nadu, throughout quite a few vital manufacturing sectors.
India’s $150-200 billion commerce proposal now hangs in uncertainty via a number of key diplomatic channels. New Delhi has signaled no additional concessions can be found, marking a agency stance amid rising stress that encompasses a number of important negotiation parts. This India US commerce conflict state of affairs might speed up BRICS greenback commerce initiatives as nations search options to US-dominated frameworks throughout varied main financial sectors.
For BRICS, Washington’s aggressive flip might function a unifying catalyst that has leveraged sure crucial alliance dynamics. Moderately than fracturing the bloc’s affect, these pharmaceutical tariffs and US commerce protectionism measures might strengthen BRICS resolve throughout quite a few vital cooperation areas.
